Nasu Y et al. |
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. |
2008 |
Osteoarthr. Cartil. |
pmid:18226559
|
Liu Y and Li S |
A Cell Culture Model of Latent and Lytic Herpes Simplex Virus Type 1 Infection in Spiral Ganglion. |
2015 |
ORL J. Otorhinolaryngol. Relat. Spec. |
pmid:26022499
|
Chatterjee A et al. |
An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. |
2010 |
Org. Lett. |
pmid:20104892
|
Cosner CC and Helquist P |
Concise, convergent syntheses of (±)-trichostatin A utilizing a Pd-catalyzed ketone enolate α-alkenylation reaction. |
2011 |
Org. Lett. |
pmid:21688856
|
Vanommeslaeghe K et al. |
Ab initio study of the binding of Trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP). |
2003 |
Org. Biomol. Chem. |
pmid:12968347
|
Gan YH and Zhang S |
PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. |
2009 |
Oral Oncol. |
pmid:19574087
|
Maldonado L et al. |
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. |
2014 |
Oncotarget |
pmid:24980822
|
Wilson-Edell KA et al. |
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. |
2014 |
Oncotarget |
pmid:24970821
|
Chen L et al. |
PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer. |
2017 |
Oncotarget |
pmid:28060760
|
Kikuchi M et al. |
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. |
2016 |
Oncotarget |
pmid:26646320
|
Choi SA et al. |
A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma. |
2017 |
Oncotarget |
pmid:27852054
|
Piao J et al. |
Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC. |
2016 |
Oncotarget |
pmid:27507059
|
Perez-Janices N et al. |
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis. |
2015 |
Oncotarget |
pmid:26284587
|
Lee YR et al. |
Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation. |
2015 |
Oncotarget |
pmid:26125438
|
Chiba T et al. |
Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. |
2004 |
Oncology |
pmid:15452378
|
Tamannai M et al. |
The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. |
2010 |
Oncol. Res. |
pmid:20681406
|
Lin S et al. |
Silencing of ATP4B of ATPase H/K Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. |
2017 |
Oncol. Res. |
pmid:28281974
|
Kumar KS et al. |
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. |
2006 |
Oncol. Rep. |
pmid:17016591
|
Kang FW et al. |
Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. |
2012 |
Oncol. Rep. |
pmid:22552321
|
Meng J et al. |
The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. |
2012 |
Oncol. Rep. |
pmid:22552631
|
Rhodes LV et al. |
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. |
2012 |
Oncol. Rep. |
pmid:21971930
|
Kim SH et al. |
Regulation of the HIF-1alpha stability by histone deacetylases. |
2007 |
Oncol. Rep. |
pmid:17273746
|
Anh TD et al. |
The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells. |
2012 |
Oncol. Rep. |
pmid:21993600
|
Ganslmayer M et al. |
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells. |
2004 |
Oncol. Rep. |
pmid:15069530
|
Ma X et al. |
Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A. |
2015 |
Oncol. Rep. |
pmid:25420545
|
Wang B et al. |
Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. |
2014 |
Oncol. Rep. |
pmid:25224651
|
Wang JH et al. |
HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells. |
2018 |
Oncol. Rep. |
pmid:29767267
|
Zhang X et al. |
Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling. |
2018 |
Oncol. Rep. |
pmid:29393444
|
Ji M et al. |
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. |
2015 |
Oncol. Rep. |
pmid:25813246
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
Wu DS et al. |
Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. |
2013 |
Oncol. Rep. |
pmid:24064951
|
Shao G et al. |
Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation. |
2017 |
Oncol. Rep. |
pmid:28393191
|
Nakajima S et al. |
Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231. |
2009 |
Oncol. Rep. |
pmid:19513516
|
Zuo X et al. |
Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. |
2014 |
Oncol. Rep. |
pmid:24676336
|
Yanada M et al. |
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. |
2005 |
Oncol. Rep. |
pmid:16142337
|
Jia L et al. |
Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375. |
2017 |
Oncol. Rep. |
pmid:27878285
|
Zhang NH et al. |
Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells. |
2016 |
Oncol. Rep. |
pmid:27373420
|
Kang HR et al. |
Butyrate-mediated acquisition of chemoresistance by human colon cancer cells. |
2016 |
Oncol. Rep. |
pmid:27277338
|
Qiao F et al. |
Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. |
2012 |
Oncol. Rep. |
pmid:22825043
|
Liu Z et al. |
Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. |
2008 |
Oncol. Rep. |
pmid:18575731
|
Wang SC et al. |
Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1‑survivin downregulation at the late phase of treatment. |
2017 |
Oncol. Rep. |
pmid:28713892
|
Puppin C et al. |
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. |
2011 |
Oncol. Rep. |
pmid:21152868
|
Androutsopoulos VP and Spandidos DA |
Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity. |
2017 |
Oncol. Rep. |
pmid:29039546
|
Zhang X et al. |
Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. |
2006 |
Oncol. Rep. |
pmid:16865256
|
Villanueva R et al. |
Histone deacetylase 3 represses HTLV-1 tax transcription. |
2006 |
Oncol. Rep. |
pmid:16865259
|
Puppin C et al. |
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. |
2011 |
Oncol. Rep. |
pmid:21617864
|
Seo JS et al. |
Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. |
2008 |
Oncol. Rep. |
pmid:18097580
|
Meng CF et al. |
Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. |
2009 |
Oncol. Rep. |
pmid:19787243
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|